High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions-Reference-Cited by-同舟云学术

High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions

Published:2019-04 Issue:2 Volume:27 Page:631-647.e5
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Mues Marsilius,Karra Laila,Romero-Moya Damia,Wandler Anica,Hangauer Matthew J.,Ksionda Olga,Thus Yvonne,Lindenbergh Marthe,Shannon Kevin,McManus Michael T.,Roose Jeroen P.

Funder

Gabrielle's Angel Foundation

Alex’s Lemonade Stand Foundation Innovator Award

NIH/NCI

NIH/NHLBI

Leukemia & Lymphoma Society

NIH

American Cancer Society

Hillcrest Committee

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference90 articles.

1. Combinatorial drug therapy for cancer in the post-genomic era;Al-Lazikani;Nat. Biotechnol.,2012

2. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia;Aur;Blood,1971

3. STK33 kinase activity is nonessential in KRAS-dependent cancer cells;Babij;Cancer Res.,2011

4. Oncogenic PI3K deregulates transcription and translation;Bader;Nat. Rev. Cancer,2005

5. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines;Badinloo;Fundam. Clin. Pharmacol.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia;Journal of Controlled Release;2023-09

2. Screening and Development of Constitutively Synergistic Combination Drug Formulations for T Cell Acute Lymphoblastic Leukemia;2022-09-22

3. Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer;Mammalian Genome;2021-07-28

4. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol;Frontiers in Oncology;2021-03-11

5. Investigating increased hematopoietic stem cell fitness in a novel mouse model;Small GTPases;2021-02-10